Keyphrases
Non-coding RNA (ncRNA)
100%
Cancer Patients
100%
Cell-free
100%
Metastasis-associated Lung Adenocarcinoma Transcript 1 (MALAT1)
100%
Non-cancer
66%
Tumor-specific
66%
RNA Molecules
66%
RNA Isolation
66%
CDNA Synthesis
66%
Preamplification
66%
Quantitative PCR
33%
RNA Expression
33%
Genomic DNA (gDNA)
33%
Expression Pattern
33%
Prostate Cancer
33%
Paris
33%
New Entity
33%
Isolation Method
33%
Bladder Cancer
33%
Protocol Optimization
33%
Prognostic Biomarker
33%
TaqMan
33%
Enhanced Sensitivity
33%
Preanalytical Variables
33%
Kidney Cancer
33%
Tissue Specificity
33%
Qiagen
33%
Urological Cancer
33%
Column Purification
33%
Master Mix
33%
Isolation Kit
33%
Preamp
33%
Erasers
33%
Reagent Kits
33%
Circulating lncRNAs
33%
MiRNA Extraction
33%
DNA Contamination
33%
Limit of Detection
33%
Long Non-coding RNA (LncRNA)
33%
Applied Biosystems
33%
Preanalytical Factors
33%
Circulating RNA
33%
Kidney Patients
33%
Medicine and Dentistry
Malignant Neoplasm
100%
Long Untranslated RNA
100%
Complementary DNA
100%
Diseases
100%
Neoplasm
50%
Real Time Polymerase Chain Reaction
50%
Prostate Cancer
50%
Bladder Cancer
50%
Tumor Marker
50%
microRNA
50%
Specific Tumor
50%
Phenol
50%
Kidney Cancer
50%
Urinary Tract Tumor
50%
Copurification
50%
Biochemistry, Genetics and Molecular Biology
RNA
100%
Long Non-Coding RNA
100%
MALAT1
60%
RNA Isolation
40%
Copurification
20%
MicroRNA
20%
TaqMan
20%
DNA Contamination
20%
Real-Time Polymerase Chain Reaction
20%
Isolation Procedure
20%
Tumor Marker
20%
Blood Plasma
20%